UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6251
Purple Innovation
PRPL
$41.7M
| $271K | ﹤0.01% |
13,898
+12,824
| +1,194% | +$290K |
|
|
PPT
6252
Franklin Premier Income Trust
PPT
$328M
| $271K | ﹤0.01% |
76,062
-21,568
| -22% | -$77.6K |
|
6253
Insteel Industries
IIIN
$625M
| $270K | ﹤0.01% |
10,012
+566
| +6% | +$16.5K |
|
6254
CALL
Dominion Energy
D
$59.3B
| $270K | ﹤0.01% |
5,020
| – | – |
|
6255
Franklin Intelligent Machines ETF
IQM
$108M
| $270K | ﹤0.01% |
+4,042
| New | +$267K |
|
6256
Mercer International
MERC
$39.8M
| $270K | ﹤0.01% |
41,522
+35,842
| +631% | +$235K |
|
6257
CALL
International Paper
IP
$22B
| $269K | ﹤0.01% |
5,000
-125,000
| -96% | -$6.7M |
|
6258
AXS Green Alpha ETF
NXTE
$51.5M
| $269K | ﹤0.01% |
8,459
+8,424
| +24,069% | +$279K |
|
6259
Myomo
MYO
$56.2M
| $268K | ﹤0.01% |
41,655
+1,177
| +3% | +$5.73K |
|
6260
Viemed Healthcare
VMD
$371M
| $268K | ﹤0.01% |
33,392
+16,109
| +93% | +$140K |
|
6261
Cricut
CRCT
$1.22B
| $267K | ﹤0.01% |
46,906
+11,199
| +31% | +$67.3K |
|
|
DMB
6262
BNY Mellon Municipal Bond Infrastructure Fund
DMB
$196M
| $267K | ﹤0.01% |
25,828
-2,840
| -10% | -$30.6K |
|
6263
ECB Bancorp
ECBK
$181M
| $267K | ﹤0.01% |
18,000
-5,701
| -24% | -$85.3K |
|
|
CMRX
6264
DELISTED
Chimerix, Inc.
CMRX
| $267K | ﹤0.01% |
76,748
-14,636
| -16% | -$20.7K |
|
|
ACB
6265
Aurora Cannabis
ACB
$185M
| $266K | ﹤0.01% |
62,539
+62,311
| +27,329% | +$306K |
|
6266
AdvisorShares Pure US Cannabis ETF
MSOS
$880M
| $266K | ﹤0.01% |
69,710
-1,615
| -2% | -$8.71K |
|
6267
Allot
ALLT
$383M
| $265K | ﹤0.01% |
44,563
+37,616
| +541% | +$152K |
|
6268
CALL
Syndax Pharmaceuticals
SNDX
$1.82B
| $264K | ﹤0.01% |
+20,000
| New | +$342K |
|
6269
Exagen
XGN
$166M
| $263K | ﹤0.01% |
64,217
-14,310
| -18% | -$51.6K |
|
6270
Schwab 1000 Index ETF
SCHK
$5.92B
| $263K | ﹤0.01% |
9,300
+4,098
| +79% | +$117K |
|
6271
Duluth Holdings
DLTH
$159M
| $263K | ﹤0.01% |
85,108
+6,812
| +9% | +$24.8K |
|
6272
Xenon Pharmaceuticals
XENE
$6.12B
| $263K | ﹤0.01% |
6,705
-6,585
| -50% | -$272K |
|
6273
CALL
Insmed
INSM
$28.6B
| $262K | ﹤0.01% |
+3,800
| New | +$274K |
|
6274
Atlanticus Holdings
ATLC
$1.52B
| $262K | ﹤0.01% |
4,699
+2,094
| +80% | +$99.5K |
|
|
GPMT
6275
Granite Point Mortgage Trust
GPMT
$61.2M
| $262K | ﹤0.01% |
93,895
+56,188
| +149% | +$177K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.